174 related articles for article (PubMed ID: 23740024)
1. Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.
Takeuchi M; Matsuzaki K; Harada M
Eur Radiol; 2013 Sep; 23(9):2358-63. PubMed ID: 23740024
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of benign and malignant uterine corpus tumors by using proton MR spectroscopy at 3T: preliminary study.
Takeuchi M; Matsuzaki K; Harada M
Eur Radiol; 2011 Apr; 21(4):850-6. PubMed ID: 20890704
[TBL] [Abstract][Full Text] [Related]
3. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.
Namimoto T; Yamashita Y; Awai K; Nakaura T; Yanaga Y; Hirai T; Saito T; Katabuchi H
Eur Radiol; 2009 Nov; 19(11):2756-64. PubMed ID: 19504102
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of 3 T MR spectroscopy, diffusion-weighted MRI, and apparent diffusion coefficient value for distinguishing benign from malignant myometrial tumours.
Rahimifar P; Hashemi H; Malek M; Ebrahimi S; Tabibian E; Alidoosti A; Mousavi A; Yarandi F
Clin Radiol; 2019 Jul; 74(7):571.e9-571.e18. PubMed ID: 31010584
[TBL] [Abstract][Full Text] [Related]
5. Preliminary observations and diagnostic value of lipid peak in ovarian thecomas/fibrothecomas using in vivo proton MR spectroscopy at 3T.
Takeuchi M; Matsuzaki K; Harada M
J Magn Reson Imaging; 2012 Oct; 36(4):907-11. PubMed ID: 22585396
[TBL] [Abstract][Full Text] [Related]
6. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
Tsujimura A; Kawamura N; Ichimura T; Honda K; Ishiko O; Ogita S
Int J Oncol; 2002 Feb; 20(2):361-5. PubMed ID: 11788902
[TBL] [Abstract][Full Text] [Related]
8. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.
Tamai K; Koyama T; Saga T; Morisawa N; Fujimoto K; Mikami Y; Togashi K
Eur Radiol; 2008 Apr; 18(4):723-30. PubMed ID: 17929022
[TBL] [Abstract][Full Text] [Related]
9. Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features.
Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Yuki H; Oda S; Utsunomiya D; Yamashita Y
Acad Radiol; 2019 Oct; 26(10):1390-1399. PubMed ID: 30661978
[TBL] [Abstract][Full Text] [Related]
10. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
11. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.
Malek M; Gity M; Alidoosti A; Oghabian Z; Rahimifar P; Seyed Ebrahimi SM; Tabibian E; Oghabian MA
Eur J Radiol; 2019 Jan; 110():203-211. PubMed ID: 30599861
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.
Abdel Wahab C; Jannot AS; Bonaffini PA; Bourillon C; Cornou C; Lefrère-Belda MA; Bats AS; Thomassin-Naggara I; Bellucci A; Reinhold C; Fournier LS
Radiology; 2020 Nov; 297(2):361-371. PubMed ID: 32930650
[TBL] [Abstract][Full Text] [Related]
13. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.
Valdes-Devesa V; Jimenez MDM; Sanz-Rosa D; Espada Vaquero M; Alvarez Moreno E; Sainz de la Cuesta Abbad R
J Obstet Gynaecol; 2019 Jan; 39(1):98-104. PubMed ID: 30207503
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy features of uterine leiomyomas.
Celik O; Sarac K; Hascalik S; Alkan A; Mizrak B; Yologlu S
Gynecol Obstet Invest; 2004; 58(4):194-201. PubMed ID: 15286450
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of susceptibility-weighted MR sequence for the evaluation of uterine sarcomas.
Takeuchi M; Matsuzaki K; Harada M
Clin Imaging; 2019; 53():143-150. PubMed ID: 30340078
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475
[TBL] [Abstract][Full Text] [Related]
17. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.
Russo F; Mazzetti S; Grignani G; De Rosa G; Aglietta M; Anselmetti GC; Stasi M; Regge D
Eur Radiol; 2012 May; 22(5):1131-9. PubMed ID: 22138734
[TBL] [Abstract][Full Text] [Related]
18. Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma.
Kawamura N; Ichimura T; Ito F; Shibata S; Takahashi K; Tsujimura A; Ishiko O; Haba T; Wakasa K; Ogita S
Cancer; 2002 Mar; 94(6):1713-20. PubMed ID: 11920533
[TBL] [Abstract][Full Text] [Related]
19. [Malignancy of uterine sarcoma in comparison with suspect leiomyoma. An anatomo-clinical study of 16 cases].
Socolov RV; Pricop FZ; Stratan D
Rev Fr Gynecol Obstet; 1992 Oct; 87(10):457-60. PubMed ID: 1470817
[TBL] [Abstract][Full Text] [Related]
20. Screening for uterine tumours.
Van den Bosch T; Coosemans A; Morina M; Timmerman D; Amant F
Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):257-66. PubMed ID: 22078749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]